Dr Reddy's Laboratories - 23 Year Stock Price History | RDY

Historical daily share price chart and data for Dr Reddy's Laboratories since 2001 adjusted for splits and dividends. The latest closing stock price for Dr Reddy's Laboratories as of November 19, 2024 is 14.35.
  • The all-time high Dr Reddy's Laboratories stock closing price was 16.84 on August 21, 2024.
  • The Dr Reddy's Laboratories 52-week high stock price is 16.89, which is 17.7% above the current share price.
  • The Dr Reddy's Laboratories 52-week low stock price is 12.90, which is 10.1% below the current share price.
  • The average Dr Reddy's Laboratories stock price for the last 52 weeks is 14.92.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Dr Reddy's Laboratories Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 15.0054 14.0828 16.8420 13.3929 14.3500 3.73%
2023 12.2330 10.2136 14.4686 10.1899 13.8343 35.40%
2022 10.7246 12.7890 12.7890 9.4609 10.2176 -20.30%
2021 12.8676 13.8432 14.6343 11.2697 12.8204 -7.48%
2020 10.6576 7.8161 14.0745 6.7114 13.8568 76.80%
2019 7.4077 7.2063 8.2018 6.7249 7.8374 8.38%
2018 6.4483 7.2424 7.5181 5.4171 7.2312 1.25%
2017 7.3714 8.5754 8.8131 5.7251 7.1417 -16.42%
2016 8.6960 8.5674 10.2417 7.7360 8.5452 -1.64%
2015 10.5422 9.3542 12.7225 8.1733 8.6875 -7.75%
2014 8.6208 7.4740 10.8998 7.1717 9.4176 23.76%
2013 6.7840 6.2965 7.6391 5.8987 7.6094 24.12%
2012 5.8198 5.5080 6.4050 5.0075 6.1307 14.03%
2011 6.1065 6.6464 6.9865 5.3107 5.3765 -18.30%
2010 5.4542 4.3956 7.4351 4.1235 6.5805 53.85%
2009 2.7106 1.7899 4.6165 1.2991 4.2773 148.96%
2008 2.3218 3.1842 3.1842 1.3201 1.7181 -45.69%
2007 2.8355 3.1355 3.2186 2.5136 3.1633 0.33%
2006 2.6409 1.8810 3.2891 1.8810 3.1528 69.17%
2005 1.5591 1.6905 1.8853 1.2962 1.8637 9.64%
2004 1.7456 2.7431 2.8121 1.2927 1.6999 -36.95%
2003 1.9393 1.6670 2.7380 1.5008 2.6962 64.49%
2002 1.6185 1.6235 2.0124 1.1668 1.6391 2.30%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $11.978B $3.350B
Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Bausch Health Cos (BHC) Canada $3.012B 2.18
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00